<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) September 25, 2000
------------------
COMMONWEALTH BIOTECHNOLOGIES, INC.
----------------------------------
(Exact name of registrant as specified in charter)
Virginia 001-13467 56-1641133
--------------- --------- ----------
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification No.)
incorporation)
601 Biotech Drive, Richmond, Virginia 23235
------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (804) 648-3820
---------------
N/A
---------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events.
On September 27, 2000, the Registrant issued a press release announcing the
completion of a $2.6 million private placement of common stock and warrants to
purchase common stock to a single accredited investor. Such press release is
included as an exhibit to this Current Report on Form 8-K.
Item 7. Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release, dated September 27, 2000, announcing the completion
of a $2.6 million private placement of common stock and warrants to
purchase common stock to a single investor.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
COMMONWEALTH BIOTECHNOLOGIES, INC.
By: /s/ Richard J. Freer, Ph.D.
---------------------------
Richard J. Freer, Ph.D.
Chairman
September 28, 2000
3
<PAGE>
EXHIBIT INDEX
Number Description of Exhibit
------ ----------------------
99.1 Press Release, dated September 27, 2000
4
